Stapled Antimicrobial Peptide ssTAMP2 Stability and Specificity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial peptides (AMPs) face challenges such as instability in biological fluids, unfavorable pharmacokinetics, hemolytic effects, and limited effectiveness against multi-drug resistant bacteria, necessitating the development of specifically targeted and stable AMPs.
Innovation Solution
The development of a stapled and specifically targeted antimicrobial peptide (ssTAMP2) with a unique sequence and structure, including alpha-4-n-pentenyl alanine residues and a hydrocarbon staple, which enhances stability and specificity for targeting pathogens.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional antimicrobial peptides are used, then antimicrobial activity is achieved, but stability in biological fluids deteriorates
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of amino acid residues within the peptide sequence. Specifically, certain amino acid residues are replaced with chemically modified analogs that resist proteolytic degradation while preserving the peptide's antimicrobial function. This structural parameter modification enhances stability in biological fluids without compromising antimicrobial activity.
Solution Approach 2:
The patent employs composite material principles by creating a hybrid peptide structure that combines natural amino acid residues with non-natural, protease-resistant analogs. This composite approach integrates the biological compatibility of natural peptides with the enhanced stability of synthetic components, resulting in a peptide that maintains both antimicrobial activity and resistance to degradation in biological environments.
2Reliability
If antimicrobial peptides are used, then antibacterial effects are achieved, but hemolytic effects worsen
Solution Approach 1:
The patent applies local quality by introducing specific chemical modifications at particular positions within the peptide sequence, rather than uniformly modifying the entire structure. By strategically placing protease-resistant amino acid analogs at specific locations, the peptide maintains its antibacterial activity while reducing off-target effects on red blood cells, thereby minimizing hemolytic effects.
Solution Approach 2:
The patent modifies specific parameters of the peptide structure, including the charge distribution, hydrophobicity, and conformational flexibility, by replacing certain amino acid residues with modified analogs. These parameter changes fine-tune the peptide's selectivity, enhancing its antibacterial activity while reducing its interaction with and damage to mammalian cell membranes, thus decreasing hemolytic effects.
3Reliability
If conventional antibiotics are used, then treatment of bacterial infections is achieved, but antimicrobial resistance worsens
Solution Approach 1:
The patent substitutes the conventional antibiotic mechanism with a peptide-based mechanism that operates through physical-chemical interactions rather than specific molecular targets. The stapled peptide acts through membrane disruption and electrostatic interactions with bacterial cell surfaces, a mechanism that is difficult for bacteria to resist through traditional target modification, thereby overcoming antimicrobial resistance.
Solution Approach 2:
The patent employs parameter changes by designing a peptide with optimized charge density, hydrophobicity, and structural rigidity that enables it to effectively target and disrupt bacterial membranes. These parameter optimizations allow the peptide to maintain high effectiveness against bacterial infections while exhibiting a novel mechanism of action that bypasses conventional resistance pathways.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
ssTAMP2 demonstrates potent antibacterial activity against a range of bacteria, including multi-drug resistant strains, while minimizing cytotoxicity and maintaining stability in biological environments, making it a promising candidate for treating microbial infections and potentially cancer.
Implementation Method 1
the stapling strategy relies on fixing α-helix structures of AMPs, thereby, overcoming the limitation of using AMPs
Implementation Method 2
the electrostatic interactions between AMPs and the target's cell membrane (negatively charged) can initiate binding
Implementation Method 3
positively charged molecules with hydrophilic and hydrophobic regions
Data Source
AI summary
A stapled and specifically targeted antimicrobial peptide having the amino acid sequence LPSTGEKDTAVERNGGFFRKSKEK-S5-GKE-S5-KRIV (SEQ ID NO: 1) and its use as an antimicrobial and anticancer agent are provided.